Spaulding Clinical Announces Expansion into Europe

January 9, 2012 – West Bend, Wisconsin, USA – Spaulding Clinical Research, LLC., a US-based leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announces it has expanded its presence into Europe with the appointment of Katie Wessel to the newly created position of Manager of Business Development – Europe.

“As we continue to grow and form strategic partnerships with drug research companies around the world, we want to continue to expand and fortify a global presence for Spaulding Clinical,” states Randol Spaulding, Founder and CEO of Spaulding Clinical Research.  “With the appointment of Katie to this dedicated position in Europe, Spaulding Clinical is taking the next step toward becoming a truly global company.”

Katie has been with Spaulding Clinical since the company’s inception in 2007.  Previously, Katie held an Associate Director position and over the past four years she has been involved in several areas of business operations, including Sales, Clinical Operations, and Recruitment.

“Katie has been a key part of Spaulding Clinical’s success and we are excited for her to take on this new role,” said Kevin Geno, Vice President of Global Sales at Spaulding Clinical.  “Katie brings a wealth of talents to this new position, including the successful management of critical departments at Spaulding Clinical, an understanding of the company’s core systems and processes, and an extreme focus on the customer.”

In her new role, Katie will be responsible for overseeing all of Spaulding Clinical’s business development activities in Europe.

Spaulding Clinical Research, LLC (www.spauldingclinical.com) provides Clinical Pharmacology, Cardiac Core Lab clinical research services, and is a medical device manufacturer. Spaulding Clinical operates a 105-bed clinical pharmacology unit with 96-beds of telemetry in West Bend, Wisconsin, USA. The facility is paperless, with a Phase I Electronic Data Capture system and bi-directional interfaces to safety lab, bedside devices and telemetry. As a Phase I-IV Core ECG Laboratory provider, Spaulding Clinical offers the complete suite of equipment provisioning and electrocardiograph over-reading services with state-of-the-art technologies, including the proprietary Spaulding Electrocardiograph, and expertly trained cardiologists and project managers.

 

Spaulding Clinical Media Contact

Kathy Forde

Sr. Director of Marketing

Tel:  (414) 303-1912

Email:  [email protected]